世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Multiplex Testing Reagents Market Size, Share & Trend Analysis By Type (Biotin-based Reagents, Streptavidin-based Reagents), By Application (Autoimmune Disease Diagnostics, Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2033

Multiplex Testing Reagents Market Size, Share & Trend Analysis By Type (Biotin-based Reagents, Streptavidin-based Reagents), By Application (Autoimmune Disease Diagnostics, Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2033


Multiplex Testing Reagents Market Summary The global multiplex testing reagents market size was estimated at USD 1.42 billion in 2024 and is expected to reach USD 4.15 billion by 2033, growing ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Grand View Research
グランドビューリサーチ
2025年11月4日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
電子ファイル - ご注文後3営業日前後 150 英語

英語原文をAIを使って翻訳しています。


 

Summary

Multiplex Testing Reagents Market Summary

The global multiplex testing reagents market size was estimated at USD 1.42 billion in 2024 and is expected to reach USD 4.15 billion by 2033, growing at a CAGR of 13.08% from 2025 to 2033. Multiplex testing reagents enable the simultaneous detection of multiple analytes in a single test, offering higher efficiency and cost-effectiveness compared to conventional single-target assays.

Their ability to provide comprehensive diagnostic data in shorter timeframes has driven adoption across clinical, research, and pharmaceutical applications. The market’s growth is further fueled by the increasing demand for personalized medicine, where rapid and precise detection of multiple biomarkers is critical for tailoring treatment strategies. Technological advancements in assay design, automation, and detection platforms have also enhanced the reliability and throughput of multiplex testing, making it an attractive choice for laboratories aiming to optimize workflow while minimizing sample volume and operational costs.

A primary factor driving the growth of multiplex testing reagents is the rising prevalence of chronic diseases and infectious conditions worldwide. Chronic illnesses such as cardiovascular disorders, cancer, autoimmune diseases, and metabolic syndromes often involve multiple biomarkers, making multiplex assays an efficient tool for comprehensive monitoring and diagnosis. In addition, the global burden of infectious diseases, including viral, bacterial, and emerging pathogens, has increased the need for high-throughput diagnostic solutions capable of detecting multiple pathogens simultaneously. Multiplex reagents allow clinicians to screen for co-infections and identify pathogen profiles in a single test, reducing diagnostic delays. This is particularly important in public health scenarios where early detection can prevent outbreaks. Consequently, growing disease prevalence directly correlates with increased adoption of multiplex testing reagents, thereby driving market expansion.

Technological innovation is a key driver of market growth for multiplex testing reagents. Advanced assay platforms, such as bead-based flow cytometry, microarrays, and next-generation sequencing-compatible reagents, have enhanced the sensitivity, specificity, and throughput of multiplex testing. Automation and integration with laboratory information systems have further streamlined workflows, allowing laboratories to process larger sample volumes with reduced human error. Novel reagent chemistries and labeling techniques have improved the detection of low-abundance biomarkers, expanding clinical and research applications. In addition, miniaturization and microfluidic technologies have enabled point-of-care multiplex testing, bringing laboratory-grade analysis closer to patients. These technological improvements not only improve diagnostic accuracy but also reduce turnaround time and costs, making multiplex testing reagents increasingly attractive for hospitals, diagnostic laboratories, and research institutions globally.

Global Multiplex Testing Reagents Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiplex testing reagents market report based on type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Biotin-based Reagents
o Biotinylated Antibodies
o Biotinylated Probes/primers
o Biotin-tagged Proteins/enzymes
• Streptavidin-based Reagents
o Streptavidin-conjugated Beads/microspheres
o Streptavidin-conjugated Enzymes & Fluorophores
o Recombinant Streptavidin Variants (engineered for higher stability)
o Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Autoimmune Disease Diagnostics
• Infectious Disease Diagnostics
• Oncology
• Allergy Testing
• Research & Translational Medicine
• Drug Discovery & Development
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical & Diagnostic Laboratories
• Hospitals
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Multiplex Testing Reagents Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type Segment
1.1.1.2. Application Method
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Multiplex Testing Reagents Market: Executive Summary
2.1. Market Snapshot
2.2. Type
2.3. Application Snapshot
2.4. End Use Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Multiplex Testing Reagents Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Growing demand for precision diagnostics and personalized medicine
3.4.2. Technological advancements in multiplex assay platforms
3.4.3. Rising r&d investments in drug discovery and translational research
3.5. Market Restraint Analysis
3.5.1. High cost of multiplex assay reagents and equipment
3.5.2. Complex validation and standardization challenges
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Multiplex Testing Reagents Market: Type Estimates & Trend Analysis
4.1. Multiplex Testing Reagents Market: Type Movement Analysis
4.2. Multiplex Testing Reagents Market by Type Outlook (USD Million)
4.3. Biotin-based Reagents
4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2. Biotinylated Antibodies
4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3. Biotinylated Probes/primers
4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.4. Biotin-tagged Proteins/enzymes
4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Streptavidin-based Reagents
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Streptavidin-conjugated Beads/microspheres
4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Streptavidin-conjugated Enzymes & Fluorophores
4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Recombinant Streptavidin Variants (engineered for higher stability)
4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Others
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Multiplex Testing Reagents Market: Application Method Estimates & Trend Analysis
5.1. Multiplex Testing Reagents Market: Application Method Movement Analysis
5.2. Multiplex Testing Reagents Market by Application Outlook (USD Million)
5.3. Autoimmune Disease Diagnostics
5.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Infectious Disease Diagnostics
5.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Oncology
5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Allergy Testing
5.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Research & Translational Medicine
5.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Drug Discovery & Development
5.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Multiplex Testing Reagents Market: End Use Estimates & Trend Analysis
6.1. Multiplex Testing Reagents Market: End Use Movement Analysis
6.2. Multiplex Testing Reagents Market by End Use Outlook (USD Million)
6.3. Clinical & Diagnostic Laboratories
6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Hospitals
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Pharmaceutical & Biotechnology Companies
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Contract Research Organizations (CROs)
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Academic & Research Institutes
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Multiplex Testing Reagents Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Multiplex Testing Reagents Market Estimates And Forecast, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia Pacific
7.4.1. Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.5.2. Key Country Dynamics
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Scenario
7.4.5.5. Competitive Scenario
7.4.6. Thailand
7.4.6.1. Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.6.2. Key Country Dynamics
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Scenario
7.4.6.5. Competitive Scenario
7.4.7. Australia
7.4.7.1. Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.4.7.2. Key Country Dynamics
7.4.7.3. Regulatory Framework
7.4.7.4. Reimbursement Scenario
7.4.7.5. Competitive Scenario
7.5. Latin America
7.5.1. Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.5.2.2. Key Country Dynamics
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Scenario
7.5.2.5. Competitive Scenario
7.5.3. Argentina
7.5.3.1. Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.5.3.2. Key Country Dynamics
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Scenario
7.5.3.5. Competitive Scenario
7.6. Middle East & Africa
7.6.1. Middle East & Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.6.2.2. Key Country Dynamics
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Scenario
7.6.2.5. Competitive Scenario
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.6.3.2. Key Country Dynamics
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Scenario
7.6.3.5. Competitive Scenario
7.6.4. UAE
7.6.4.1. UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.6.4.2. Key Country Dynamics
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Scenario
7.6.4.5. Competitive Scenario
7.6.5. Kuwait
7.6.5.1. Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
7.6.5.2. Key Country Dynamics
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Scenario
7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Acquisition
8.2.4. Collaboration
8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
8.5.1. Luminex Corporation
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Bio-Rad Laboratories, Inc.
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Abcam plc.
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Seegene Inc.
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Merck KGaA
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Illumina, Inc.
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Promega Connections
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. QIAGEN N.V.
8.5.8.1. Company Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Thermo Fisher Scientific
8.5.9.1. Company Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. PerkinElmer Inc.
8.5.10.1. Company Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
8.5.11. Bio-Techne Corporation
8.5.11.1. Company Overview
8.5.11.2. Financial Performance
8.5.11.3. Product Benchmarking
8.5.11.4. Strategic Initiatives
8.5.12. BD
8.5.12.1. Company Overview
8.5.12.2. Financial Performance
8.5.12.3. Product Benchmarking
8.5.12.4. Strategic Initiatives

ページTOPに戻る



List of Tables/Graphs

List of Tables

Table 1 List of abbreviation
Table 2 North America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
Table 3 North America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 4 North America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 5 North America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 6 U.S. multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 7 U.S. multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 8 U.S. multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 9 Canada multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 10 Canada multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 11 Canada multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 12 Mexico multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 13 Mexico multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 14 Mexico multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 15 Europe multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
Table 16 Europe multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 17 Europe multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 18 Europe multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 19 Germany multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 20 Germany multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 21 Germany multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 22 UK multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 23 UK multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 24 UK multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 25 France multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 26 France multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 27 France multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 28 Italy multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 29 Italy multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 30 Italy multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 31 Spain multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 32 Spain multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 33 Spain multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 34 Denmark multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 35 Denmark multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 36 Denmark multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 37 Sweden multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 38 Sweden multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 39 Sweden multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 40 Norway multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 41 Norway multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 42 Norway multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 43 Asia Pacific multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
Table 44 Asia Pacific multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 45 Asia Pacific multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 46 Asia Pacific multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 47 China multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 48 China multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 49 China multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 50 Japan multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 51 Japan multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 52 Japan multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 53 India multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 54 India multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 55 India multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 56 South Korea multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 57 South Korea multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 58 South Korea multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 59 Australia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 60 Australia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 61 Australia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 62 Thailand multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 63 Thailand multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 64 Thailand multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 65 Latin America multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
Table 66 Latin America multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 67 Latin America multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 68 Latin America multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 69 Brazil multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 70 Brazil multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 71 Brazil multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 72 Argentina multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 73 Argentina multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 74 Argentina multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 75 Middle East & Africa multiplex testing reagents market, by region, 2021 - 2033 (USD Million)
Table 76 Middle East & Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 77 Middle East & Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 78 Middle East & Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 79 South Africa multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 80 South Africa multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 81 South Africa multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 82 Saudi Arabia multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 83 Saudi Arabia multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 84 Saudi Arabia multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 85 UAE multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 86 UAE multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 87 UAE multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)
Table 88 Kuwait multiplex testing reagents market, by type, 2021 - 2033 (USD Million)
Table 89 Kuwait multiplex testing reagents market, by application, 2021 - 2033 (USD Million)
Table 90 Kuwait multiplex testing reagents market, by end use, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global Multiplex Testing Reagents Market - Key market driver analysis
Fig. 7 Global Multiplex Testing Reagents Market - Key market restraint analysis
Fig. 8 Penetration & growth prospect mapping
Fig. 9 Global Multiplex Testing Reagents Market - Porter’s analysis
Fig. 10 Global Multiplex Testing Reagents Market - PESTEL analysis
Fig. 11 Global Multiplex Testing Reagents Market Type outlook key takeaways
Fig. 12 Global Multiplex Testing Reagents Market: Type movement analysis
Fig. 13 Biotin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
Fig. 14 Biotinylated Antibodies Market Estimates, 2021 - 2033 (USD Million)
Fig. 15 Biotinylated Probes/primers Market Estimates, 2021 - 2033 (USD Million)
Fig. 16 Biotin-tagged Proteins/enzymes Market Estimates, 2021 - 2033 (USD Million)
Fig. 17 Streptavidin-based Reagents Market Estimates, 2021 - 2033 (USD Million)
Fig. 18 Streptavidin-conjugated Beads/microspheres Market Estimates, 2021 - 2033 (USD Million)
Fig. 19 Streptavidin-conjugated Enzymes & Fluorophores Market Estimates, 2021 - 2033 (USD Million)
Fig. 20 Recombinant Streptavidin Variants (engineered for higher stability) Market Estimates, 2021 - 2033 (USD Million)
Fig. 21 Others Market Estimates, 2021 - 2033 (USD Million)
Fig. 22 Global Multiplex Testing Reagents Market Application outlook key takeaways
Fig. 23 Global Multiplex Testing Reagents Market: Application movement analysis
Fig. 24 Autoimmune Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
Fig. 25 Infectious Disease Diagnostics Market Estimates, 2021 - 2033 (USD Million)
Fig. 26 Oncology Market Estimates, 2021 - 2033 (USD Million)
Fig. 27 Allergy Testing Market Estimates, 2021 - 2033 (USD Million)
Fig. 28 Research & Translational Medicine Market Estimates, 2021 - 2033 (USD Million)
Fig. 29 Drug Discovery & Development Market Estimates, 2021 - 2033 (USD Million)
Fig. 30 Others Market Estimates, 2021 - 2033 (USD Million)
Fig. 31 Global Multiplex Testing Reagents Market End Use outlook key takeaways
Fig. 32 Global Multiplex Testing Reagents Market End Use movement analysis
Fig. 33 Clinical & Diagnostic Laboratories Market Estimates, 2021 - 2033 (USD Million)
Fig. 34 Hospitals Market Estimates, 2021 - 2033 (USD Million)
Fig. 35 Pharmaceutical & Biotechnology Companies Market Estimates, 2021 - 2033 (USD Million)
Fig. 36 Contract Research Organizations (CROs)
Fig. 37 Academic & Research Institutes Market Estimates, 2021 - 2033 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global Multiplex Testing Reagents Market: Regional movement analysis
Fig. 40 North America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 41 U.S. Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 42 Canada Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 43 Mexico Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 44 Europe Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 45 UK Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 46 Germany Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 47 France Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 48 Spain Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 49 Italy Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 50 Denmark Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 51 Sweden Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 52 Norway Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 53 Asia Pacific Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 54 Japan Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 55 China Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 56 India Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 57 South Korea Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 58 Australia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 59 Thailand Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 60 Latin America Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 61 Brazil Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 62 Argentina Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 63 MEA Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 64 South Africa Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 65 Saudi Arabia Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 66 UAE Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 67 Kuwait Multiplex Testing Reagents Market, 2021 - 2033 (USD Million)
Fig. 68 Strategy framework

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Grand View Research社の 臨床検査分野 での最新刊レポート

本レポートと同じKEY WORD(reagents)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2025/12/18 10:27

156.61 円

184.19 円

212.11 円

ページTOPに戻る